TraceIQ Launched to Maximize Pharmaceutical Traceability
TraceIQ, which was developed and being marketing by Systech, combines enterprise traceability, operational intelligence, and AI-assisted investigations to help manufacturers prevent disruptions, accelerate exception resolution, and improve product availability. The post TraceIQ Launched to Maximize Pharmaceutical Traceability appeared first on GEN - Genetic Engineering and Biotechnology News .
Systech introduced TraceIQ, an advanced enterprise traceability platform, to enhance the operational aspects of pharmaceutical and biopharma supply chains. While early traceability systems focused on meeting serialization requirements, complying with regulators, and sharing data with trading partners, Patnala, Systech's general manager, stated that compliance alone is insufficient in today's complex supply chains.
Patnala explained that as regulations evolve and supply chains become more intricate across sites, contract manufacturing organizations (CMOs), logistics providers, and regulators, teams must resolve issues swiftly and maintain product flow with limited resources. Traditional traceability solutions, serving as systems of record, often fall short in quickly identifying root causes, coordinating across partners, and implementing corrective actions, which can lead to delays, shipment holds, and inefficiencies.
TraceIQ addresses these challenges by merging core compliance features with an operational intelligence layer, powered by AI-driven analytics and insights, tailored to the modern pharmaceutical supply chain. The platform transforms traceability data from mere transaction records into a dynamic source of insights, empowering teams to detect patterns, investigate causes, and collaborate with partners.
Patnala outlined three key operational objectives of TraceIQ: preventing issues before they disrupt product flow through built-in validation and guardrails, resolving exceptions promptly with centralized data and AI-assisted investigations, and converting traceability data into actionable decisions via intuitive search, analytics, and intelligent assistance.
He emphasized that TraceIQ benefits a wide range of organizations, from emerging biopharmaceutical firms to global manufacturers and contract organizations, by unlocking greater value from serialization and traceability investments, thereby enhancing operational visibility, productivity, and informed decision-making.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
